What is the equity of Prestige Biologics Co this year?
Prestige Biologics Co has equity of 99.8 B KRW this year.
Prestige Biologics Co Equity 2024
Prestige Biologics Co Equity
99.8 B KRW
Prestige Biologics Co Dividend yield
Ticker
334970.KQ
ISIN
KR7334970001
In 2024, Prestige Biologics Co's equity was 99.8 B KRW, a -15.14% increase from the 117.61 B KRW equity in the previous year.
Prestige Biologics Co Aktienanalyse
What does Prestige Biologics Co do?
Prestige Biologics Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Prestige Biologics Co's Equity
Prestige Biologics Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Prestige Biologics Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Prestige Biologics Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Prestige Biologics Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Prestige Biologics Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Prestige Biologics Co Stock
What was the equity of Prestige Biologics Co compared to the previous year?
The equity of Prestige Biologics Co has increased/decreased by -15.14% decreased compared to the previous year.
What impact does a high equity have on investors of Prestige Biologics Co?
A high equity is advantageous for investors of Prestige Biologics Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Prestige Biologics Co?
A low equity can be a risk for investors of Prestige Biologics Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Prestige Biologics Co affect the company?
An increase in equity of Prestige Biologics Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Prestige Biologics Co affect the company?
A reduction in equity of Prestige Biologics Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Prestige Biologics Co?
Some factors that can affect the equity of Prestige Biologics Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Prestige Biologics Co so important for investors?
The equity of Prestige Biologics Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Prestige Biologics Co take to change the equity?
To change equity, Prestige Biologics Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Prestige Biologics Co pay?
Over the past 12 months, Prestige Biologics Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Prestige Biologics Co is expected to pay a dividend of 0 KRW.
What is the dividend yield of Prestige Biologics Co?
The current dividend yield of Prestige Biologics Co is .
When does Prestige Biologics Co pay dividends?
Prestige Biologics Co pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Prestige Biologics Co?
Prestige Biologics Co paid dividends every year for the past 0 years.
What is the dividend of Prestige Biologics Co?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is Prestige Biologics Co located?
Prestige Biologics Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Prestige Biologics Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Prestige Biologics Co from 6/11/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 6/11/2024.
When did Prestige Biologics Co pay the last dividend?
The last dividend was paid out on 6/11/2024.
What was the dividend of Prestige Biologics Co in the year 2023?
In the year 2023, Prestige Biologics Co distributed 0 KRW as dividends.
In which currency does Prestige Biologics Co pay out the dividend?
The dividends of Prestige Biologics Co are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Prestige Biologics Co
Our stock analysis for Prestige Biologics Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Prestige Biologics Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Prestige Biologics Co Revenue
- Prestige Biologics Co Net Income
- Prestige Biologics Co P/E
- Prestige Biologics Co P/S
- Prestige Biologics Co EBIT
- Prestige Biologics Co Dividend
- Prestige Biologics Co Stocks
- Prestige Biologics Co Market capitalization
- Prestige Biologics Co Debt
- Prestige Biologics Co Liabilities
- Prestige Biologics Co Equity
- Prestige Biologics Co AAQS
- Prestige Biologics Co Employees
- Prestige Biologics Co ROE
- Prestige Biologics Co ROA
- Prestige Biologics Co ROCE